Review On Breast Cancer And It’s Treatment : Capivasertib and combination with fulvestrant

Registration ID: IJNRD_213148

Published ID: IJNRD2401308

DOI: Click Here to Get

Gaikwad Nikita Prakash , Gajare Asawari Sham

Breast cancer, Capivasertib, fulvestrant, biomarkers ,immunomodulation .

This study has been undertake A Bosom disease, or breast cancer, is a malignant tumor that develops from breast cells. It can originate in different parts of the breast, including the ducts that carry milk to the nipple or the glands that produce milk. Over time, these cancerous cells can invade nearby tissues and spread to other parts of the body. More than half of bosom growths harbor modifications in at least one qualities of the phosphatidylinositol 3-kinase (PI3K) pathway including PIK3CA changes (31%), PTEN misfortune (34%), PTEN transformations (5%) and AKT1 transformations (3%). While PI3K and mTOR inhibitors are as of now endorsed in cutting edge bosom disease, AKT inhibitors have been as of late evolved as another restorative methodology. Capivasertib (AZD5363) is a novel, specific ATP-cutthroat skillet AKT kinase inhibitor that applies comparable action against the three AKT isoforms, AKT1, AKT2, and AKT3

Published Paper   E-Certificate

Gaikwad Nikita Prakash & Gajare Asawari Sham (January-2024). Review On Breast Cancer And It’s Treatment : Capivasertib and combination with fulvestrant . INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 9(1), d66-d73. https://ijnrd.org/papers/IJNRD2401308.pdf

Volume 9 Issue 1, January-2024

Pages : d66-d73

Paper Reg. ID: IJNRD_213148

Published Paper Id: IJNRD2401308

Downloads: 000121984

Research Area: Pharmacy

Country: Ahmednagar , MAHARASHTRA, India

Published Paper PDF: https://ijnrd.org/papers/IJNRD2401308.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2401308

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG

This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition

Call For Paper - Volume 10 | Issue 10 | October 2025

IJNRD is a Scholarly Open Access, Peer-reviewed, and Refereed Journal with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost Journal that follows UGC CARE 2025 Peer-Reviewed Journal Policy norms, Scopus journal standards, and Transparent Peer Review practices to ensure quality and credibility. IJNRD provides indexing in all major databases & metadata repositories, a citation generator, and Digital Object Identifier (DOI) for every published article with full open-access visibility.

The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse fields. Its goal is to promote global scientific information exchange among researchers, developers, engineers, academicians, and practitioners. IJNRD serves as a platform where educators and professionals can share research evidence, models of best practice, and innovative ideas, contributing to academic growth and industry relevance.

Indexing Coverage includes Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many more recognized academic repositories.

How to submit the paper?

By Our website

Click Here to Submit Paper Online

By Mail

Send your paper to editor@ijnrd.org

Important Dates for Current issue

Paper Submission Open For: October 2025

Current Issue: Volume 10 | Issue 10 | October 2025

Impact Factor: 8.76

Last Date for Paper Submission: Till 31-Oct-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.

Subject Category: Research Area

Call for Paper: More Details